Hepatitis C virus screening and management of seroconversions in hemodialysis facilities

Seminars in Dialysis

Volumn 26, Issue 4, 2013, Pages 439-446

  Mbaeyi, Chukwuma ^a,b   Thompson, Nicola D ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; CROSS INFECTION; DISEASE TRANSMISSION; EPIDEMIC; FEMALE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION CONTROL; ISOLATION AND PURIFICATION; MALE; MASS SCREENING; METHODOLOGY; OUTPATIENT DEPARTMENT; PRACTICE GUIDELINE; PREVALENCE; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; STANDARD; SURVIVAL; UNITED STATES;

AMBULATORY CARE FACILITIES; COMMUNICABLE DISEASE CONTROL; CROSS INFECTION; DISEASE OUTBREAKS; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HEMODIALYSIS UNITS, HOSPITAL; HEPACIVIRUS; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RENAL DIALYSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84880696704     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12097     Document Type: Article

References (56)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ: The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144(10):705-714, 2006
2. Hoofnagle JH: Hepatitis C: the clinical spectrum of disease. Hepatology [Consensus Development Conference Review] 26(3 Suppl 1):15S-20S, 1997
3. Ghany MG, Strader DB, Thomas DL, Seeff LB: Diagnosis, management, and treatment of hepatitis C. Hepatology 49(4):1335-1374, 2009
4. Alter MJ: The epidemiology of acute and chronic hepatitis C. Clin Liver Dis 1(3):559-568, 1997, vi-vii
5. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 47(RR-19):1-39, 1998
6. Perz JF, Thompson ND, Schaefer MK, Patel PR: US outbreak investigations highlight the need for safe injection practices and basic infection control. Clin Liver Dis 14(1):137-151, 2010
7. Petrosillo N, Gilli P, Serraino D, Dentico P, Mele A, Ragni P, Puro V, Casalino C, Ippolito G: Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis 37(5):1004-1010, 2001
8. Thompson ND, Novak RT, Datta D, Cotter S, Arduino MJ, Patel PR, Williams IT, Bialek SR: Hepatitis C virus transmission in hemodialysis units: importance of infection control practices and aseptic technique. Infect Control Hosp Epidemiol 30(9):900-903, 2009
9. Thompson ND, Perz JF, Moorman AC, Holmberg SD: Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Ann Intern Med 150(1):33-39, 2009
10. Okuda K, Hayashi H, Kobayashi S, Irie Y: Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients. J Hepatol 23(1):28-31, 1995
11. Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ: National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 18(1):52-61, 2005
12. Shimokura G, Chai F, Weber DJ, Samsa GP, Xia GL, Nainan OV, Tobler LH, Busch MP, Alter MJ: Patient-care practices associated with an increased prevalence of hepatitis C virus infection among chronic hemodialysis patients. Infect Control Hosp Epidemiol 32(5):415-424, 2011
13. Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN, Akiba T, Young EW: Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 65:2335-2342, 2004
14. Centers for Disease Control and Prevention (CDC). Healthcare-associated hepatitis B and C outbreaks reported to the Centers for Disease Control and Prevention (CDC) in 2008-2011; Available from: http://www.cdc.gov/hepatitis/Outbreaks/HealthcareHepOutbreakTable.htm. [cited 2012 November 15]
15. Patel PR, Thompson ND, Kallen AJ, Arduino MJ: Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients. Am J Kidney Dis 56(2):371-378, 2010
16. Centers for Disease Control and Prevention (CDC). Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 50(RR-5):1-43, 2001
17. Mbaeyi C, Agarwal A, Belflower R, Mercedes L, Tuttle J, Kolhe P, Xia G, Ramachandran S, Khudyakov Y, Hu D, Thompson N, Patel P, Arduino M, Nielsen C, Schaefer M, Wise M: Outbreak of hepatitis C virus infections in an outpatient dialysis facility-Georgia, 2011. 61st Annual Epidemic Intelligence Service (EIS) Conference, April 16-20, 2012; Atlanta, GA
18. Centers for Disease Control and Prevention (CDC). Hepatitis C virus transmission at an outpatient hemodialysis unit-New York, 2001-2008. MMWR Morbid Mortal Wkly Rep 58(8):189-194, 2009
19. Chan TM, Lok ASF, Cheng IKP, Chan RT: Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology 17(1):5-8, 1993
20. Sampietro M, Salvadori S, Corbetta N, Badalamenti S, Graziani G, Fiorelli G: Single-tube reverse transcription and heminested polymerase chain reaction of hepatitis C virus RNA to detect viremia in serologically negative hemodialysis patients. Int J Clin Lab Res 25(1):52-54, 1995
21. Stuyver L, Claeys H, Wyseur A, Van Arnhem W, De Beenhouwer H, Uytendaele S, Beckers J, Matthijs D, Leroux-Roels G, Maertens G, De Paepe M: Hepatitis C virus in a hemodialysis unit: molecular evidence for nosocomial transmission. Kidney Int 49(3):889-895, 1996
22. Schröter M, Feucht H-H, Schäfer P, Zöllner B, Laufs R: High percentage of seronegative HCV infections in hemodialysis patients: the need for PCR. Intervirology 40(4):277-278, 1997
23. Le Pogam S, Le Chapois D, Christen R, Dubois F, Barin F, Goudeau A: Hepatitis C in a hemodialysis unit: molecular evidence for nosocomial transmission. J Clin Micro 36(10):3040-3043, 1998
24. Alter HJ, Jett BW, Polito AJ, Farci P, Melpolder JC, Shih JW-K, Shimizu Y, Purcell R: Analysis of the role of hepatitis C virus in transfusion-associated hepatitis. In: Hollinger FB, Lemon SM, Margolis H (eds). Viral Hepatitis and Liver Disease. Baltimore, MD: Williams & Williams, 1991:396-402
25. Kidney Disease: Improving Global Outcomes. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney disease. Kidney Int 73 (Suppl 109):S1-S99, 2008
26. Department of Health & Human Services. National Action Plan to Prevent Healthcare-Associated Infections: Roadmap to Elimination; Available from: http://www.hhs.gov/ash/initiatives/hai/esrd.html. [cited 2012 November 15]
27. Sacks-Davis R, VAN Gemert C, Bergeri I, Stoove M, Hellard M: Identifying newly acquired cases of hepatitis C using surveillance: a literature review. Epidemiol Infect 140(11):1925-1934, 2012
28. Centers for Disease Control and Prevention. Reference for interpretation of hepatitis C virus (HCV) test results; Available from: http://www.cdc.gov/hepatitis/HCV/PDFs/hcv_graph.pdf. [cited 2012 November 27]
29. Centers for Disease Control and Prevention (CDC). Guideline for viral hepatitis surveillance and case management, 2005; Available from: http://www.cdc.gov/hepatitis/Statistics/SurveillanceGuidelines.htm. [cited 2012 August 24]
30. Centers for Disease Control and Prevention (CDC). Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Morb Mortal Wkly Rep 61(RR-4):1-32, 2012
31. Gupta S, Singh R: Analysis of the virus dynamics model reveals that early treatment of HCV infection may lead to the sustained virological response. PLoS ONE 7(7):e41209, 2012
32. Nunnari G, Montineri A, Portelli V, Savalli F, Fatuzzo F, Cacopardo B: The use of peginterferon in monotherapy or in combination with ribavirin for the treatment of acute hepatitis C. Eur Rev Med Pharmacol Sci 16(8):1013-1016, 2012
33. Sherman KE: Therapeutic approach to the treatment-naive patient with hepatitis C virus genotype 1 infection: a step-by-step approach. Clin Infect Dis 55(9):1236-1241, 2012
34. Council of State & Territorial Epidemiologists (CSTE). Public health reporting and national notification for acute hepatitis C; Available from: http://www.cste.org/ps2009/09-ID-40.pdf. [cited 2012 November 14]
35. Centers for Medicare & Medicaid Services. ESRD program interpretative guidance; Available from: http://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/downloads/SCletter09-01.pdf. [cited 2012 November 15]
36. Dudzinski DM, Hébert PC, Foglia MB, Gallagher TH: The disclosure dilemma-large-scale adverse events. N Engl J Med 363(10):978-986, 2010
37. Centers for Medicare & Medicaid Services: Medicare and Medicaid programs: conditions for coverage for end-stage renal disease facilities: final rule. Fed Reg 73(73):20369-20484, 2008
38. Centers for Disease Control and Prevention (CDC). Continuing Education Course: Infection prevention in dialysis settings; Available from: http://www.cdc.gov/dialysis/provider/CE/infection-prevent-outpatient-hemo.html. [cited 2012 August 27]
39. Alter MJ: Healthcare should not be a vehicle for transmission of hepatitis C virus. J Hepatol 48(1):2-4, 2008
40. Williams IT, Perz JF, Bell BP: Viral hepatitis transmission in ambulatory health care settings. Clin Infect Dis 38(11):1592-1598, 2004
41. Trepanier CA, Lessard MR, Brochu JG, Denault PH: Risk of cross-infection related to the multiple use of disposable syringes. Can J Anaesth 37(2):156-159, 1990
42. Centers for Disease Control and Prevention (CDC). Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopy clinic-Nevada, 2007. MMWR Morb Mortal Wkly Rep 57(19):513-517, 2008
43. Centers for Disease Control and Prevention. Injection Safety Checklist; Available at: http://www.cdc.gov/injectionsafety/PDF/SIPC_Checklist.pdf. [cited 2012 December 16]
44. Centers for Disease Control and Prevention. Infection prevention checklist for outpatient settings: minimum expectations for safe care; Available from: http://www.cdc.gov/HAI/settings/outpatient/checklist/outpatient-care-checklist.html. [cited 2013 March 11]
45. Siegel JD, Rhinehart E, Jackson M, Chiarello L: Health Care Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: Preventing transmission of infectious agents in health care settings. Am J Infect Control 35(10 Suppl 2):S65-S164, 2007
46. Alfurayh O, Sabeel A, Al Ahdal MN, Almeshari K, Kessie G, Hamid M, Dela Cruz DM: Hand contamination with hepatitis C virus in staff looking after hepatitis C-positive hemodialysis patients. Am J Nephrol 20(2):103-106, 2000
47. Centers for Disease Control and Prevention. Guideline for hand hygiene in health-care settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Recomm Rep 51(RR-16):1-45, 2002
48. Shimokura G, Weber DJ, Miller WC, Wurtzel H, Alter MJ: Factors associated with personal protection equipment use and hand hygiene among hemodialysis staff. Am J Infect Control 34(3):100-107, 2006
49. World Health Organization. Your 5 Moments for Hand Hygiene; Available from: http://www.who.int/gpsc/5may/Your_5_Moments_For_Hand_Hygiene_Poster.pdf. [cited 2013 March 11]
50. Centers for Disease Control and Prevention (CDC). Protocol for Hand Hygiene and Glove Use Observations; Available from: http://www.cdc.gov/dialysis/prevention-tools/Protocol-hand-hygiene-glove-observations.html. [cited 2012 November 14]
51. Centers for Disease Control and Prevention (CDC). Guide to Hand Hygiene Opportunities in Hemodialysis; Available from: http://www.cdc.gov/dialysis/PDFs/collaborative/Hemodialysis-Hand-Hygiene-Observations.pdf. [cited 2012 November 14]
52. Kamili S, Krawczynski K, McCaustland K, Li X, Alter MJ: Infectivity of hepatitis C virus in plasma after drying and storing at room temperature. Infect Control Hosp Epidemiol 28(5):519-524, 2007
53. Girou E, Chevaliez S, Challine D, Thiessart M, Morice Y, Lesprit P, Tkoub-Scheirlinck L, Soing-Altrach S, Cizeau F, Cavin C, André M, Dahmanne D, Lang P, Pawlotsky JM: Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit. Clin Infect Dis 47(5):627-633, 2008
54. Froio N, Nicastri E, Comandini UV, Cherubini C, Felicioni R, Solmone M, Di Giulio S, Petrosillo N: Contamination by hepatitis B and C viruses in the dialysis setting. Am J Kidney Dis 42(3):546-550, 2003
55. Centers for Disease Control and Prevention (CDC). Guideline for disinfection and sterilization in healthcare facilities, 2008; Available from: http://www.cdc.gov/hicpac/pdf/guidelines/disinfection_nov_2008.pdf. [cited 2012 August 27]
56. Centers for Disease Control and Prevention. Routine Disinfection of the Dialysis Station: User Checklist. Available from: http://www.cdc.gov/dialysis/PDFs/collaborative/Env_checklist-508.pdf. [cited 2013 April 29]